Skip to main content

Products

Galt's unique model is based on continuously pursuing a better way to enhance the life of patients with products that meet their therapeutic needs.

OUR PIPELINE

At Galt, we are deeply committed to developing transformative medications that address unmet needs. This journey demands our full commitment and investment in understanding the healthcare and disease landscape. We are dedicated to finding better ways to make a difference in the lives of patients, their caregivers, and physicians. Our approach includes rigorous research of new product concepts and exploration of new applications for existing medicines. Through this work, we strive to open new pathways to healing and support, as well as bring hope and improved outcomes to those we serve.

Doral®

Insomnia

R&D Regulatory Marketed

Norgesic®

Musculoskeletal Pain & Analgesia

R&D Regulatory Marketed

Oravig®

Oral Thrush

R&D Regulatory Marketed

Tolectin®

Osteoarthritis & Rheumatoid Arthritis

R&D Regulatory Marketed

GA-2601

Migraine

R&D Regulatory Marketed

GA-2701

Tension Headaches

R&D Regulatory Marketed

OUR PATIENT SUPPORT PROGRAMS

Our business is driven by actively seeking to bring innovative medicines to more patients through our unique business model. We believe it's important to develop and market medications that meet unmet clinical needs and ensure that those who need those medications can obtain them. Patients facing financial hardships, especially those without insurance coverage for prescription medicines, may be eligible for patient assistance support programs.

Our Galt Direct Help Desk is ready to support patients, caregivers, and providers to ensure patient needs are met. Contact our Help Desk at 855-965-2783 or at helpdesk@galtrx.com.